Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Systemic lupus erythematosus Stories

2012-10-18 23:20:35

WASHINGTON, Oct. 19, 2012 /PRNewswire-USNewswire/ -- Whoopi Goldberg, physician and renowned researcher Dr. Michael Lockshin, and humanitarians Judith and Wayne Barlin were honored for their work to improve the lives of people with lupus, at the Lupus Foundation of America's annual Butterfly Gala in New York City on October 18. (Photo: http://photos.prnewswire.com/prnh/20121019/DC96318) (Logo: http://photos.prnewswire.com/prnh/20120711/DC38337LOGO) Other special guests at the Gala...

2012-10-17 22:24:16

A new clinical study published in BioMedCentral's open access journal Arthritis Research and Therapy provides preliminary evidence that vitamin D supplementation could be considered an immunomodulatory agent for systemic lupus erythematosus (SLE), a debilitating autoimmune disease characterized not only by skin, joint, neurological and renal symptoms, but also by inflammation of tissue linings in the body. SLE is a T- and B-cell-dependent disease that causes an appearance of...

2012-10-15 07:28:23

ANAHEIM, Calif., Oct. 15, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will release third quarter 2012 financial results on Tuesday, October 23, 2012 after the close of the U.S. financial markets. The Company will host a conference call and slide presentation via webcast on Tuesday, October 23, 2012 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss results and highlights of the quarter, as well as current corporate developments. The...

2012-09-24 02:26:08

SAN DIEGO, Sept. 24, 2012 /PRNewswire/ -- Genalyte, Inc. today announced that it is hosting a webinar to show participants how they can generate multiplexed autoantibody assay results in a one-step, 15 minute process. Genalyte's Maverick(TM) Detection System uses a silicon chip containing arrays of photonic ring sensors that simultaneously analyze multiple antibodies and other proteins from a single small sample. The webinar, Chip-Based Multiplex Autoantibody Detection, is scheduled for...

2012-09-19 14:21:40

ANAHEIM, Calif., Sept. 19, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it will conduct a conference call to discuss the reimbursement process for H.P. Acthar Gel (repository corticotrophin injection) prescriptions. The call will take place on Thursday, September 20, 2012 at 11 a.m. ET, 8 a.m. PT. The call can be accessed in the following ways: By webcast: At Questcor's investor relations website: http://ir.questcor.com/. By telephone: For both...

2012-09-17 02:25:41

HAYWARD, Calif., Sept. 17, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today provided an update on regulatory discussions for the global development of blisibimod. End of Phase 2 discussions with the US Food and Drug Administration (FDA) have been completed and will allow for the submission of Phase 3 protocols and the initiation of registration...

2012-09-16 23:03:54

LocalEdge to assist in raising critically needed funds and awareness of Lupus this month by sponsoring the 2012 Walk Now for Lupus Fayetteville, NC (PRWEB) September 15, 2012 On Saturday September 22, 2012, LocalEdge will support the local Piedmont Chapter of the Lupus Foundation of America, Inc. by serving as a Silver Sponsor of this year´s Walk for Lupus Now. The event is scheduled to take place at Festival Park on 335 Ray Avenue in Fayetteville. Registration begins at 3:30 and the...

2012-09-11 10:24:41

EMERYVILLE, Calif., Sept. 11, 2012 /PRNewswire/ -- AllCells, LLC, a leading provider of healthy & diseased hematopoietic tissues, primary cell types, and related services to the global life science industry has announced the release of new autoimmune diseased cells and tissue products. The specimens may be used in preclinical research, drug discovery, drug toxicity, diagnostic related assays, and other life science research applications. All products are indicated for in vitro...

2012-08-17 14:20:41

IRVINE, Calif., Aug. 17, 2012 /PRNewswire/ -- Guard A Heart Foundation, a non-profit organization, raising awareness for cardiovascular disease by educating individuals about the dangers of vulnerable plaque, is pleased to announce the appointment of Dr. Bahar Sedarati as its Scientific Spokesperson and Ambassador. Dr. Sedarati's responsibilities will include supporting Guard A Heart through peer to peer speaking engagements and contributing her expertise through education and...

2012-08-07 10:26:18

HAYWARD, Calif., Aug. 7, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2012. Financial Results: Total operating expenses for the second quarter ended June 30, 2012 were $16.7 million, as compared to $20.1 million for the first quarter ended March 31, 2012. The decrease in operating expenses for the period is related to the reduced clinical activity following the completion of...